It remains unknown how cardiomyocyte GCH1 is modulated in DCM, and whether cardiomyocyte-targeted increase of GCH1 proteins benefits intracellular Ca2+ signaling, thus improving cardiac function in diabetes. Here, GCH1 is linked to diabetes mellitus.